Answers are grounded in this paper and cite their sources.
Although CD68 is widely used as a clinical pan‐macrophage marker, its sensitivity and specificity for identifying macrophage populations are inconsistent. Consequently, reports on the role of macrophages in primary melanoma outcomes have been conflicting. Aims To evaluate the sensitivity of ionised calcium‐binding adaptor molecule 1 ( IBA1) compared with CD68 for identifying tumour‐associated macrophages ( TAMs ) in primary melanoma, and to assess the distribution and clinical relevance of TAMs . Methods and results Human melanoma samples from the Western Australian Melanoma Health Study ( WAMHS ) were analysed using multiplex immunofluorescence to compare IBA1 and CD68 staining. IBA1 was more sensitive than CD68 for detecting TAMs , revealing an increased apparent TAM density. TAMs were abundant across melanomas of all thicknesses and were predominantly localised to tumour margins. However, TAM density was not associated with melanoma‐specific survival. Conclusions IBA1 is a sensitive and reliable pan‐macrophage marker for quantifying TAM abundance and distribution in melanoma. Despite their abundance at tumour margins, total TAM density does not predict survival, highlighting the need to further investigate their functional roles in tumour progression.
No takes yet. Share an insight, caveat, or question.
Ng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: